Citius Pharmaceuticals, Inc. (CTXR)

NASDAQ: CTXR · Real-Time Price · USD

0.7556

+0.0220 (3.00%)

At close: Aug 14, 2026, 4:00 PM EDT

0.6801

-0.0755 (-9.99%)

After-hours: Aug 14, 2026, 7:58 PM EDT

Citius Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Selling, General & Admin	54.14	29.37	30.09	21.91	15.66	11.29
Research & Development	6.5	9.16	11.91	14.82	17.66	12.24
Operating Expenses	60.64	38.53	42	36.73	33.32	23.53
Operating Income	-56.15	-38.53	-42	-36.73	-33.32	-23.53
Interest Expense	-0.46	-0.27	-	-	-	-0.01
Interest & Investment Income	0.17	0.11	0.76	1.18	0.25	0.26
EBT Excluding Unusual Items	-56.43	-38.68	-41.24	-35.55	-33.06	-23.28
Gain (Loss) on Sale of Assets	3.83	-	2.39	3.59	-	-
Other Unusual Items	-	-	-	-	-	0.23
Pretax Income	-54.89	-38.68	-38.85	-31.97	-33.06	-23.05
Income Tax Expense	0.56	1.06	0.58	0.58	0.58	-
Earnings From Continuing Operations	-55.45	-39.74	-39.43	-32.54	-33.64	-23.05
Minority Interest in Earnings	9.25	2.31	0.29	-	-	-
Net Income	-46.2	-37.43	-39.14	-32.54	-33.64	-23.05
Preferred Dividends & Other Adjustments	-	-	1.05	1.15	-	1.45
Net Income to Common	-46.2	-37.43	-40.19	-33.69	-33.64	-24.51
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	18	11	7	6	6	4
Shares Outstanding (Diluted)	18	11	7	6	6	4
Shares Change	138.25%	64.49%	11.16%	3.57%	34.52%	177.28%
EPS (Basic)	-2.56	-3.38	-5.97	-5.57	-5.76	-5.64
EPS (Diluted)	-2.56	-3.38	-5.97	-5.57	-5.76	-5.64
EPS Growth	-	-	-	-	-	-
Free Cash Flow	-31.6	-26.55	-28.2	-29.06	-28.36	-24.26
Free Cash Flow Per Share	-1.75	-2.40	-4.19	-4.80	-4.85	-5.58
EBITDA	-53.85	-38.52	-41.99	-36.73	-33.31	-23.53
D&A For EBITDA	2.29	0	0	0	0	0
EBIT	-56.15	-38.53	-42	-36.73	-33.32	-23.53

SEC Filings: 10-K · 10-Q